Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesStudy: Intervention raises costs for diabetes
Medical Economics, 10/21/09
Lewis M – Medical interventions for patients with type 2 diabetes won't reduce health costs over the long term, according to a recently published study, but that doesn't mean they don't offer benefits.
Related Articles
Autosomal recessive familial neurohypophyseal diabetes insipidus - onset in early infancy
European Journal of Endocrinology, 11/10/09
Relevance Score: 67%
Diverse Vasopressin V2 Receptor Functionality Underlying Partial Congenital Nephrogenic Diabetes Insipidus
American Journal of Physiology: Renal Physiology, 10/08/09
Relevance Score: 65%
Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus
Nephron: Physiology, 10/08/09
Relevance Score: 65%
Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy
Journal of Neuro-Oncology, 10/14/09
Relevance Score: 64%
Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09
Relevance Score: 48%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
"Better Ways to Pay for Health Care", Recommended by National Health Care Quality Coalition
AMN Healthcare, 11/25/09
Stimulating EMR adoption
American Medical News , 11/25/09
Rising mortality and life expectancy differentials by lifetime earnings in the United States
Journal of Health Economics, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor